Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT04869774 |
Other study ID # |
20200596-01H |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
May 2021 |
Est. completion date |
February 2022 |
Study information
Verified date |
April 2021 |
Source |
University of Ottawa |
Contact |
Reilly Musselman, MD, MSc |
Phone |
613-798-5555 |
Email |
rmusselman[@]toh.ca |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The purpose of this study is to assess the feasibility of using a mobile application (app)
called how2trak to improve people's experience, wound surveillance, and detection of surgical
site infections (SSI) after colorectal surgery while reducing in-person interactions for
patients during the COVID-19 pandemic.
This will inform the implementation of a full-scale trial to establish if surveillance of
someone's incision and symptoms using how2trak improves SSI detection and management compared
to standard care (involving a single post-operative surgery clinic visit).
The data collected will contribute to a broader dataset of people with SSI surveillance to be
used in developing a clinical decision support system.
Description:
Background: Surgical site infections (SSI) are the most common nosocomial infection and occur
in 16.3% of individuals undergoing colorectal surgery at our institution, the majority of
which are identified after discharge from hospital. Patients concerned to have an SSI,
generally present to the emergency department or surgery clinic. Both options for in-person
interaction are costly to the healthcare system and patients, and increase their risk of
COVID-19 exposure. A mobile application How2trak has proven to be beneficial for patients
with complex wounds at our institution by facilitating at-home monitoring and virtual
consultations.
Aim: This study aims to assess the feasibility of a randomized controlled trial to assess if
How2trak can improve patients' experience, and detection of surgical site infections after
colorectal surgery while reducing their risk of COVID-19 exposure.
Methods: In this single-center, prospective feasibility trial, eligible patients undergoing
elective and semi-urgent colorectal surgery will be randomized to either standard care or
How2trak post-operative monitoring of their incision, symptoms, and ostomy function. Patient
self-assessments will be monitored by a nurse specialized in wound and ostomy care who will
meet virtually with the patient as needed. The primary outcome is feasibility as measured by
enrollment, randomization, H2T usability, data extraction, and resource capacity.
Results: We anticipate this work will help us to better understand the feasibility of using
mobile technology to optimize patients' care after discharge from hospital after colorectal
surgery. Virtual post-surgery wound and symptom monitoring could enhance patient experience,
SSI detection, and reduce the risk of COVID-19 transmission. If this technology is feasible
for our patient population and workflow, next steps will be to assess its effectiveness with
a full-scale randomized controlled trial and explore additional applications including ostomy
monitoring, patient education, and application in other surgical departments.